The role of GLI2-ABCG2 signaling axis for 5Fu resistance in gastric cancer

Beiqin Yu^{a, b},
Dongsheng Gu^b,
Xiaoli Zhang^b,
Bingya Liu^{a
, ,},
Jingwu Xie^{b
, ,}

a.
Shanghai Key Laboratory of Gastric Neoplasms, Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
b.
Departments of Pediatrics, Biochemistry and Molecular Biology, Pharmacology and Toxicology, The Wells Center for Pediatrics Research and IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA

More Information

Corresponding author: E-mail address: jinxie@iu.edu (Bingya Liu); E-mail address: liubingya@sjtu.edu.cn (Jingwu Xie)

摘要

- /
- /
- /
- /
Abstract: Gastric cancer is a leading cause of cancer-related mortality worldwide, and options to treat gastric cancer are limited. Fluorouracil (5Fu)-based chemotherapy is frequently used as a neoadjuvant or an adjuvant agent for gastric cancer therapy. Most patients with advanced gastric cancer eventually succumb to the disease despite the fact that some patients respond initially to chemotherapy. Thus, identifying molecular mechanisms responsible for chemotherapy resistance will help design novel strategies to treat gastric cancer. In this study, we discovered that residual cancer cells following 5Fu treatment have elevated expression of hedgehog (Hg) target genesGLI1 and GLI2, suggestive of Hh signaling activation. Hh signaling, a pathway essential for embryonic development, is an important regulator for putative cancer stem cells/residual cancer cells. We found that high GLI1/GLI2 expression is associated with some features of putative cancer stem cells, such as increased side population. We demonstrated that GLI2 knockdown sensitized gastric cancer cells to 5Fu treatment, decreased ABCG2 expression, and reduced side population. Elevated GLI2 expression is also associated with an increase in tumor sphere size, another marker for putative cancer stem cells. We believe that GLI2 regulates putative cancer stem cells through direct regulation of ABCG2. ABCG2 can rescue the GLI2 shRNA effects in 5Fu response, tumor sphere formation and side population changes, suggesting that ABCG2 is an important mediator for GLI2-associated 5Fu resistance. The relevance of our studies to gastric cancer patient care is reflected by our discovery that high GLI1/GLI2/ABCG2 expression is associated with a high incidence of cancer relapse in two cohorts of gastric cancer patients who underwent chemotherapy (containing 5Fu). Taken together, we have identified a molecular mechanism by which gastric cancer cells gain 5Fu resistance.
- 5Fu /
- Gastric cancer /
- ABCG2 /
- Hedgehog /
- Gli2

HTML全文

参考文献(48)

[1]	Ajani, J.A., Bentrem, D.J., Besh, S. et al. Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines J. Natl. Compr. Canc. Netw., 11 (2013),pp. 531-546
[2]	Alonso, S., Hernandez, D., Chang, Y.T. et al. Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistance J. Clin. Invest., 126 (2016),pp. 4460-4468
[3]	Basset-Seguin, N., Sharpe, H.J., de Sauvage, F.J. Efficacy of Hedgehog pathway inhibitors in Basal cell carcinoma Mol. Cancer Ther., 14 (2015),pp. 633-641
[4]	Bernards, N., Creemers, G.J., Nieuwenhuijzen, G.A. et al. No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapy Ann. Oncol., 24 (2013),pp. 3056-3060
[5]	Chen, T., Yang, K., Yu, J. et al. Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients Cell Res., 22 (2012),pp. 248-258
[6]	Chen, W., Zhang, X., Chu, C. et al. Identification of CD44+ cancer stem cells in human gastric cancer Hepatogastroenterology, 60 (2013),pp. 949-954
[7]	Cho, R.W., Clarke, M.F. Recent advances in cancer stem cells Curr. Opin. Genet. Dev., 18 (2008),pp. 48-53
[8]	Cunningham, D., Allum, W.H., Stenning, S.P. et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N. Engl. J. Med., 355 (2006),pp. 11-20
[9]	Della Corte, C.M., Bellevicine, C., Vicidomini, G. et al. Clin. Cancer Res., 21 (2015),pp. 4686-4697
[10]	Domingo-Domenech, J., Vidal, S.J., Rodriguez-Bravo, V. et al. Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells Cancer Cell, 22 (2012),pp. 373-388
[11]	Dong, J., Li, J., Liu, S.M. et al. CD33(+)/p-STAT1(+) double-positive cell as a prognostic factor for stage IIIa gastric cancer Med. Oncol., 30 (2013),p. 442
[12]	Feldmann, G., Dhara, S., Fendrich, V. et al. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers Cancer Res., 67 (2007),pp. 2187-2196
[13]	Ferlay, J., Soerjomataram, I., Dikshit, R. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int. J. Cancer, 136 (2015),pp. E359-E386
[14]	Fukamachi, H., Shimada, S., Ito, K. et al. CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation Cancer Sci., 102 (2011),pp. 1313-1321
[15]	Ikram, M.S., Neill, G.W., Regl, G. et al. GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter J. Invest. Dermatol., 122 (2004),pp. 1503-1509
[16]	Ishimoto, T., Nagano, O., Yae, T. et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth Cancer Cell, 19 (2011),pp. 387-400
[17]	Jiang, J., Zhang, Y., Chuai, S. et al. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype Oncogene, 31 (2012),pp. 671-682
[18]	Jiang, Y., He, Y., Li, H. et al. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer Gastric Cancer, 15 (2012),pp. 440-450
[19]	Keysar, S.B., Le, P.N., Anderson, R.T. et al. Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancer Cancer Res., 73 (2013),pp. 3381-3392
[20]	Li, Z.J., Nieuwenhuis, E., Nien, W. et al. Kif7 regulates Gli2 through Sufu-dependent and -independent functions during skin development and tumorigenesis Development, 139 (2012),pp. 4152-4161
[21]	Liu, Z., Xu, J., He, J. et al. A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance Blood, 124 (2014),pp. 2061-2071
[22]	McLean, M.H., El-Omar, E.M. Genetics of gastric cancer Nat. Rev. Gastroenterol. Hepatol., 11 (2014),pp. 664-674
[23]	Motoyama, J., Liu, J., Mo, R. et al. Nat. Genet., 20 (1998),pp. 54-57
[24]	Nozawa, Y.I., Lin, C., Chuang, P.T. Hedgehog signaling from the primary cilium to the nucleus: an emerging picture of ciliary localization, trafficking and transduction Curr. Opin. Genet. Dev., 23 (2013),pp. 429-437
[25]	Orditura, M., Galizia, G., Sforza, V. et al. Treatment of gastric cancer World J. Gastroenterol., 20 (2014),pp. 1635-1649
[26]	Papanastasopoulos, P., Stebbing, J. Molecular basis of 5-fluorouracil-related toxicity: lessons from clinical practice Anticancer Res., 34 (2014),pp. 1531-1535
[27]	Persoskie, A., Ferrer, R.A. A most odd ratio::interpreting and describing odds ratios Am. J. Prev. Med., 52 (2017),pp. 224-228
[28]	Proserpio, I., Rausei, S., Barzaghi, S. et al. Multimodal treatment of gastric cancer World J. Gastrointest. Surg., 6 (2014),pp. 55-58
[29]	Rassouli, F.B., Matin, M.M., Saeinasab, M. Cancer stem cells in human digestive tract malignancies Tumour Biol., 37 (2016),pp. 7-21
[30]	Razzak, M. Genetics: new molecular classification of gastric adenocarcinoma proposed by the Cancer Genome Atlas Nat. Rev. Clin. Oncol., 11 (2014),p. 499
[31]	Reya, T., Morrison, S.J., Clarke, M.F. et al. Stem cells, cancer, and cancer stem cells Nature, 414 (2001),pp. 105-111
[32]	Rimkus, T.K., Carpenter, R.L., Qasem, S. et al. Targeting the sonic hedgehog signaling pathway: review of smoothened and GLI inhibitors Cancers; Basel, 8 (2016)
[33]	Sarkadi, B., Ozvegy-Laczka, C., Nemet, K. et al. ABCG2 – a transporter for all seasons FEBS Lett., 567 (2004),pp. 116-120
[34]	Singh, R.R., Kunkalla, K., Qu, C. et al. ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma Oncogene, 30 (2011),pp. 4874-4886
[35]	Steg, A.D., Bevis, K.S., Katre, A.A. et al. Stem cell pathways contribute to clinical chemoresistance in ovarian cancer Clin. Cancer Res., 18 (2012),pp. 869-881
[36]	Steg, A.D., Katre, A.A., Bevis, K.S. et al. Smoothened antagonists reverse taxane resistance in ovarian cancer Mol. Cancer Ther., 11 (2012),pp. 1587-1597
[37]	Taipale, J., Beachy, P.A. The Hedgehog and Wnt signalling pathways in cancer Nature, 411 (2001),pp. 349-354
[38]	Takebe, N., Miele, L., Harris, P.J. et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update Nat. Rev. Clin. Oncol., 12 (2015),pp. 445-464
[39]	Torre, L.A., Bray, F., Siegel, R.L. et al. Global cancer statistics, 2012 CA Cancer J. Clin., 65 (2015),pp. 87-108
[40]	Wang, J.C., Dick, J.E. Cancer stem cells: lessons from leukemia Trends Cell Biol., 15 (2005),pp. 494-501
[41]	Wang, T., Ong, C.W., Shi, J. et al. Sequential expression of putative stem cell markers in gastric carcinogenesis Br. J. Cancer, 105 (2011),pp. 658-665
[42]	Weiswald, L.B., Bellet, D., Dangles-Marie, V. Spherical cancer models in tumor biology Neoplasia, 17 (2015),pp. 1-15
[43]	Xu, M., Gong, A., Yang, H. et al. Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44(+)/Musashi-1(+) gastric cancer stem cells Cancer Lett., 369 (2015),pp. 124-133
[44]	Yang, L., Xie, G., Fan, Q. et al. Activation of the hedgehog-signaling pathway in human cancer and the clinical implications Oncogene, 29 (2010),pp. 469-481
[45]	Yoon, C., Cho, S.J., Aksoy, B.A. et al. Chemotherapy resistance in diffuse-type gastric adenocarcinoma is mediated by RhoA activation in cancer stem-like cells Clin. Cancer Res., 22 (2016),pp. 971-983
[46]	Yu, B., Xie, J. Identifying therapeutic targets in gastric cancer: the current status and future direction Acta Biochim. Biophys. Sin. (Shanghai), 48 (2016),pp. 90-96
[47]	Yuan, M., Yang, Y., Lv, W. et al. Paclitaxel combined with capecitabine as first-line chemotherapy for advanced or recurrent gastric cancer Oncol. Lett., 8 (2014),pp. 351-354
[48]	Zahreddine, H.A., Culjkovic-Kraljacic, B., Assouline, S. et al. The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation Nature, 511 (2014),pp. 90-93